Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Mesalazine Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Granule
1.3 Market by Application
1.3.1 Global Oral Mesalazine Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Ulcerative Colitis
1.3.3 Crohn's Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Mesalazine Market Perspective (2024-2034)
2.2 Oral Mesalazine Growth Trends by Region
2.2.1 Global Oral Mesalazine Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Oral Mesalazine Historic Market Size by Region (2024-2024)
2.2.3 Oral Mesalazine Forecasted Market Size by Region (2024-2034)
2.3 Oral Mesalazine Market Dynamics
2.3.1 Oral Mesalazine Industry Trends
2.3.2 Oral Mesalazine Market Drivers
2.3.3 Oral Mesalazine Market Challenges
2.3.4 Oral Mesalazine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Mesalazine Players by Revenue
3.1.1 Global Top Oral Mesalazine Players by Revenue (2024-2024)
3.1.2 Global Oral Mesalazine Revenue Market Share by Players (2024-2024)
3.2 Global Oral Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Mesalazine Revenue
3.4 Global Oral Mesalazine Market Concentration Ratio
3.4.1 Global Oral Mesalazine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Mesalazine Revenue in 2022
3.5 Oral Mesalazine Key Players Head office and Area Served
3.6 Key Players Oral Mesalazine Product Solution and Service
3.7 Date of Enter into Oral Mesalazine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Mesalazine Breakdown Data by Type
4.1 Global Oral Mesalazine Historic Market Size by Type (2024-2024)
4.2 Global Oral Mesalazine Forecasted Market Size by Type (2024-2034)
5 Oral Mesalazine Breakdown Data by Application
5.1 Global Oral Mesalazine Historic Market Size by Application (2024-2024)
5.2 Global Oral Mesalazine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Oral Mesalazine Market Size (2024-2034)
6.2 North America Oral Mesalazine Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Oral Mesalazine Market Size by Country (2024-2024)
6.4 North America Oral Mesalazine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Mesalazine Market Size (2024-2034)
7.2 Europe Oral Mesalazine Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Oral Mesalazine Market Size by Country (2024-2024)
7.4 Europe Oral Mesalazine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Mesalazine Market Size (2024-2034)
8.2 Asia-Pacific Oral Mesalazine Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Oral Mesalazine Market Size by Region (2024-2024)
8.4 Asia-Pacific Oral Mesalazine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Mesalazine Market Size (2024-2034)
9.2 Latin America Oral Mesalazine Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Oral Mesalazine Market Size by Country (2024-2024)
9.4 Latin America Oral Mesalazine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Mesalazine Market Size (2024-2034)
10.2 Middle East & Africa Oral Mesalazine Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Oral Mesalazine Market Size by Country (2024-2024)
10.4 Middle East & Africa Oral Mesalazine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Oral Mesalazine Introduction
11.1.4 AbbVie Revenue in Oral Mesalazine Business (2024-2024)
11.1.5 AbbVie Recent Development
11.2 Shire
11.2.1 Shire Company Detail
11.2.2 Shire Business Overview
11.2.3 Shire Oral Mesalazine Introduction
11.2.4 Shire Revenue in Oral Mesalazine Business (2024-2024)
11.2.5 Shire Recent Development
11.3 Salix Pharmaceuticals
11.3.1 Salix Pharmaceuticals Company Detail
11.3.2 Salix Pharmaceuticals Business Overview
11.3.3 Salix Pharmaceuticals Oral Mesalazine Introduction
11.3.4 Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2024-2024)
11.3.5 Salix Pharmaceuticals Recent Development
11.4 Ferring Global
11.4.1 Ferring Global Company Detail
11.4.2 Ferring Global Business Overview
11.4.3 Ferring Global Oral Mesalazine Introduction
11.4.4 Ferring Global Revenue in Oral Mesalazine Business (2024-2024)
11.4.5 Ferring Global Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Oral Mesalazine Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2024-2024)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Morningside Healthcare
11.6.1 Morningside Healthcare Company Detail
11.6.2 Morningside Healthcare Business Overview
11.6.3 Morningside Healthcare Oral Mesalazine Introduction
11.6.4 Morningside Healthcare Revenue in Oral Mesalazine Business (2024-2024)
11.6.5 Morningside Healthcare Recent Development
11.7 Dr. Falk Pharma UK
11.7.1 Dr. Falk Pharma UK Company Detail
11.7.2 Dr. Falk Pharma UK Business Overview
11.7.3 Dr. Falk Pharma UK Oral Mesalazine Introduction
11.7.4 Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2024-2024)
11.7.5 Dr. Falk Pharma UK Recent Development
11.8 Nogra Pharma Limited
11.8.1 Nogra Pharma Limited Company Detail
11.8.2 Nogra Pharma Limited Business Overview
11.8.3 Nogra Pharma Limited Oral Mesalazine Introduction
11.8.4 Nogra Pharma Limited Revenue in Oral Mesalazine Business (2024-2024)
11.8.5 Nogra Pharma Limited Recent Development
11.9 Tillotts Pharma
11.9.1 Tillotts Pharma Company Detail
11.9.2 Tillotts Pharma Business Overview
11.9.3 Tillotts Pharma Oral Mesalazine Introduction
11.9.4 Tillotts Pharma Revenue in Oral Mesalazine Business (2024-2024)
11.9.5 Tillotts Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Mesalazine Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Tablets
Table 3. Key Players of Capsules
Table 4. Key Players of Granule
Table 5. Global Oral Mesalazine Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Oral Mesalazine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Oral Mesalazine Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global Oral Mesalazine Market Share by Region (2024-2024)
Table 9. Global Oral Mesalazine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Oral Mesalazine Market Share by Region (2024-2034)
Table 11. Oral Mesalazine Market Trends
Table 12. Oral Mesalazine Market Drivers
Table 13. Oral Mesalazine Market Challenges
Table 14. Oral Mesalazine Market Restraints
Table 15. Global Oral Mesalazine Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global Oral Mesalazine Market Share by Players (2024-2024)
Table 17. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2022)
Table 18. Ranking of Global Top Oral Mesalazine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Oral Mesalazine Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Mesalazine Product Solution and Service
Table 22. Date of Enter into Oral Mesalazine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Mesalazine Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global Oral Mesalazine Revenue Market Share by Type (2024-2024)
Table 26. Global Oral Mesalazine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Oral Mesalazine Revenue Market Share by Type (2024-2034)
Table 28. Global Oral Mesalazine Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global Oral Mesalazine Revenue Market Share by Application (2024-2024)
Table 30. Global Oral Mesalazine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Oral Mesalazine Revenue Market Share by Application (2024-2034)
Table 32. North America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America Oral Mesalazine Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America Oral Mesalazine Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe Oral Mesalazine Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe Oral Mesalazine Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Oral Mesalazine Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific Oral Mesalazine Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific Oral Mesalazine Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America Oral Mesalazine Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America Oral Mesalazine Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa Oral Mesalazine Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa Oral Mesalazine Market Size by Country (2024-2034) & (US$ Million)
Table 47. AbbVie Company Detail
Table 48. AbbVie Business Overview
Table 49. AbbVie Oral Mesalazine Product
Table 50. AbbVie Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Shire Company Detail
Table 53. Shire Business Overview
Table 54. Shire Oral Mesalazine Product
Table 55. Shire Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 56. Shire Recent Development
Table 57. Salix Pharmaceuticals Company Detail
Table 58. Salix Pharmaceuticals Business Overview
Table 59. Salix Pharmaceuticals Oral Mesalazine Product
Table 60. Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 61. Salix Pharmaceuticals Recent Development
Table 62. Ferring Global Company Detail
Table 63. Ferring Global Business Overview
Table 64. Ferring Global Oral Mesalazine Product
Table 65. Ferring Global Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 66. Ferring Global Recent Development
Table 67. Teva Pharmaceutical Industries Company Detail
Table 68. Teva Pharmaceutical Industries Business Overview
Table 69. Teva Pharmaceutical Industries Oral Mesalazine Product
Table 70. Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. Morningside Healthcare Company Detail
Table 73. Morningside Healthcare Business Overview
Table 74. Morningside Healthcare Oral Mesalazine Product
Table 75. Morningside Healthcare Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 76. Morningside Healthcare Recent Development
Table 77. Dr. Falk Pharma UK Company Detail
Table 78. Dr. Falk Pharma UK Business Overview
Table 79. Dr. Falk Pharma UK Oral Mesalazine Product
Table 80. Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 81. Dr. Falk Pharma UK Recent Development
Table 82. Nogra Pharma Limited Company Detail
Table 83. Nogra Pharma Limited Business Overview
Table 84. Nogra Pharma Limited Oral Mesalazine Product
Table 85. Nogra Pharma Limited Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 86. Nogra Pharma Limited Recent Development
Table 87. Tillotts Pharma Company Detail
Table 88. Tillotts Pharma Business Overview
Table 89. Tillotts Pharma Oral Mesalazine Product
Table 90. Tillotts Pharma Revenue in Oral Mesalazine Business (2024-2024) & (US$ Million)
Table 91. Tillotts Pharma Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Mesalazine Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Oral Mesalazine Market Share by Type: 2022 VS 2034
Figure 3. Tablets Features
Figure 4. Capsules Features
Figure 5. Granule Features
Figure 6. Global Oral Mesalazine Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Oral Mesalazine Market Share by Application: 2022 VS 2034
Figure 8. Ulcerative Colitis Case Studies
Figure 9. Crohn's Disease Case Studies
Figure 10. Inflammatory Bowel Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Oral Mesalazine Report Years Considered
Figure 13. Global Oral Mesalazine Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Oral Mesalazine Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Oral Mesalazine Market Share by Region: 2022 VS 2034
Figure 16. Global Oral Mesalazine Market Share by Players in 2022
Figure 17. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral Mesalazine Revenue in 2022
Figure 19. North America Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Oral Mesalazine Market Share by Country (2024-2034)
Figure 21. United States Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Oral Mesalazine Market Share by Country (2024-2034)
Figure 25. Germany Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Oral Mesalazine Market Share by Region (2024-2034)
Figure 33. China Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Oral Mesalazine Market Share by Country (2024-2034)
Figure 41. Mexico Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Oral Mesalazine Market Share by Country (2024-2034)
Figure 45. Turkey Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Oral Mesalazine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 48. Shire Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 49. Salix Pharmaceuticals Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 50. Ferring Global Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 52. Morningside Healthcare Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 53. Dr. Falk Pharma UK Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 54. Nogra Pharma Limited Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 55. Tillotts Pharma Revenue Growth Rate in Oral Mesalazine Business (2024-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed